PH10519A - 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof - Google Patents

4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof

Info

Publication number
PH10519A
PH10519A PH16465A PH16465A PH10519A PH 10519 A PH10519 A PH 10519A PH 16465 A PH16465 A PH 16465A PH 16465 A PH16465 A PH 16465A PH 10519 A PH10519 A PH 10519A
Authority
PH
Philippines
Prior art keywords
hydroxymethyl
pharmaceutical compositions
phthalazone derivatives
phthalazone
derivatives
Prior art date
Application number
PH16465A
Other languages
English (en)
Inventor
T Shimamoto
M Ishikawa
T Tsuchiya
M Inoue
Original Assignee
Shimamoto Takio
M Ishikawa
Tsuchiya Takashi
Inoue Michiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Shimamoto Takio, M Ishikawa, Tsuchiya Takashi, Inoue Michiro filed Critical Shimamoto Takio
Publication of PH10519A publication Critical patent/PH10519A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH16465A 1973-10-30 1974-10-30 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof PH10519A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (xx) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (xx) 1973-10-31 1973-10-31

Publications (1)

Publication Number Publication Date
PH10519A true PH10519A (en) 1977-05-26

Family

ID=26458679

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16465A PH10519A (en) 1973-10-30 1974-10-30 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof

Country Status (20)

Country Link
US (1) US3963716A (xx)
AR (1) AR205004A1 (xx)
CA (1) CA1029377A (xx)
CH (2) CH610892A5 (xx)
DD (1) DD119231A5 (xx)
DE (1) DE2451417C3 (xx)
DK (1) DK134345B (xx)
ES (1) ES431454A1 (xx)
FI (1) FI59402C (xx)
FR (1) FR2248841B1 (xx)
GB (1) GB1459606A (xx)
HU (1) HU168797B (xx)
IE (1) IE39831B1 (xx)
IL (1) IL45675A (xx)
IN (1) IN139552B (xx)
LU (1) LU71191A1 (xx)
NL (1) NL7414186A (xx)
PH (1) PH10519A (xx)
SE (1) SE412389B (xx)
YU (1) YU289774A (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CA1334969C (en) * 1988-08-19 1995-03-28 Mark James Suto Substituted dihydroisoquinoline and phthalazine derivatives as potentiators of the lethal effects of radiation and certain chemotherapeutic agents, selected compounds, analogs andprocess
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE4333761A1 (de) * 1993-10-04 1995-04-06 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
ES2525748T3 (es) 2009-11-13 2014-12-29 Toray Industries, Inc. Agente terapéutico o profiláctico para la diabetes
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (xx) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
CA1029377A (en) 1978-04-11
SE412389B (sv) 1980-03-03
IL45675A (en) 1978-10-31
FR2248841A1 (xx) 1975-05-23
FI315774A (xx) 1975-05-01
CH610892A5 (xx) 1979-05-15
IE39831L (en) 1975-04-30
YU289774A (en) 1983-01-21
DD119231A5 (xx) 1976-04-12
DK134345B (da) 1976-10-25
DK134345C (xx) 1977-03-21
LU71191A1 (xx) 1975-04-17
SE7413530L (xx) 1975-05-02
IN139552B (xx) 1976-07-03
HU168797B (xx) 1976-07-28
AR205004A1 (es) 1976-03-31
DK561874A (xx) 1975-07-07
DE2451417A1 (de) 1975-05-07
US3963716A (en) 1976-06-15
ES431454A1 (es) 1976-10-16
IL45675A0 (en) 1974-11-29
DE2451417C3 (de) 1981-01-29
NL7414186A (nl) 1975-05-02
IE39831B1 (en) 1979-01-03
AU7295474A (en) 1976-03-11
FR2248841B1 (xx) 1978-07-28
CH611282A5 (xx) 1979-05-31
GB1459606A (en) 1976-12-22
FI59402C (fi) 1981-08-10
FI59402B (fi) 1981-04-30
DE2451417B2 (de) 1980-05-14

Similar Documents

Publication Publication Date Title
PH10519A (en) 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof
ZA743934B (en) Pharmaceutical compositions
PH10649A (en) Sulphoxide derivatives and pharmaceutical compositions thereof
IL43853A0 (en) Pharmaceutical compositions and their manufacture
IL44795A0 (en) Pharmaceutical compositions containing arylthioalkanols and novel arylthioalkanols
IL46050A0 (en) Azepinoquinoline derivatives,their preparation and pharmaceutical compositions containing them
GB1482552A (en) Benzomorphanes and morphinane derivatives and pharmaceutical compositions containing the same
PH12944A (en) Pyrazole derivatives and their pharmaceutical composition
IL44427A0 (en) Dibenzothiepine derivatives,their manufacture and pharmaceutical compositions containing them
HK72578A (en) Pharmaceutical compositions
IL46183A (en) 3-aminoalkylamino-1-phenoxy-2propanol derivatives,their preparation and pharmaceutical compositions comprising them
ZA744373B (en) Pharmaceutical compositions
PH11400A (en) Naphthyridine derivatives and pharmaceutical composition thereof
PH10643A (en) Benzylpyrimidine derivatives and pharmaceutical compositions thereof
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
IL44222A (en) Diphenylpropylamines their preparation and pharmaceutical compositions containing them
AU7201374A (en) Pharmaceutical compositions
ZA744488B (en) Pharmaceutical compositions
ZA745756B (en) Pharmaceutical compositions
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
ZA742064B (en) Pharmaceutical compositions
ZA747276B (en) Pharmaceutical compositions
IL45950A (en) 2-glycylamido-4-pyridyl-thiazole derivatives their preparation and pharmaceutical compositions containing them
IE39291B1 (en) Pharmaceutical compositions comprising an anzyme and substtrate
PH11919A (en) Morpholine derivatives and their pharmaceutical compositions